In a recent article featuring Genoa Healthcare, Chain Drug Review highlighted the important role pharmacy teams play in providing personalized, compassionate care to meet the needs of medically underserved communities. The article outlined the type of accessible clinical support Genoa pharmacists and pharmacy technicians can provide for patients, including medication-assisted therapies and long-acting injectable (LAI) treatments where pharmacist administration is permitted.
Often located on site within community health clinics, Genoa pharmacists are in a unique position to support patients with their treatment plans. A recent study in collaboration with Brown University, Rhode Island Hospital and the University of Rhode Island, showed Genoa pharmacists can safely and effectively treat and care for patients with opioid use disorder. The results found that patients who were treated and cared for at the pharmacy had an 89% retention rate in the medication-assisted treatment program after one month – compared to just 17% for patients who received care through traditional channels.
“Leveraging our partnerships with clinic staff and other members of the care team, our pharmacists can bridge gaps in care that make it difficult for medically underserved populations to receive the treatment they need,” said Todd Gustin, Genoa Healthcare CEO. “Our pharmacy teams are poised to make a difference in the communities we serve, and Genoa is dedicated to helping as many people as possible access needed care.”
Read the full article here or view it in Chain Drug Review’s recent issue.
